You are viewing an inactive listing

This listing is not currently available. You can either be notified when it becomes available or browse nearby active listings below.

Click here to view additional nearby listings or search by keyword.

Albuquerque, New Mexico 87106

  • Alcohol Use Disorder

Purpose:

This study will examine the efficacy of the medication gemfibrozil in reducing alcohol consumption in individuals with an alcohol use disorder who are seeking treatment for alcohol-related problems. Twenty individuals will be randomized to receive four weeks of either gemfibrozil or placebo and retrospective reports of alcohol use will be collected throughout the trial. In addition, brain imaging measures will be collected at baseline and after two weeks of treatment to determine the effects of gemfibrozil on brain functioning.


Criteria:

Inclusion Criteria: 1. males and females age 18-60 meeting DSM-V criteria for moderate or severe AUD in the past year 2. interested in cutting down or quitting drinking 3. able to provide voluntary informed consent 4. have at least 4 heavy drinking days (≥ 5 drinks per day for men, and 4 for women) in the past 30 days Exclusion Criteria: 1. severe liver disease; severe kidney disease; gallbladder disease or gallstones 2. chronic renal or hepatic failure 3. recent pancreatitis 4. insulin-dependent diabetes 5. other urgent medical problems 6. moderately elevated liver function tests (AST or ALT greater than 2 times upper limit of normal) or elevated creatine kinase (CK) 7. schizophrenia, schizoaffective disorder, Bipolar I disorder, suicidal thoughts in the last month 8. current moderate or severe other substance use disorder (SUD; except nicotine or marijuana) 9. active legal problems with the potential to result in incarceration 10. pregnancy or lactation, or child bearing age and not on birth control or not willing to use other birth control methods (e.g. condoms) 11. current daily use of anti-craving medications, mood stabilizers, benzodiazepines, or anti-psychotics 12. regularly taking a medication contraindicated for use with gemfibrozil including other fibrates, statins, repaglinide, or which are believed to interact with gemfibrozil such as dasabuvir, dabrafenib, loperamide, montelukast, paclitaxel, pioglitazone, rosiglitazone, colestipol, colchicine and warfarin41,68 13. a history of alcohol withdrawal-induced seizures or delirium tremens (hallucinations, disorientation) requiring hospital admission during the last ten years 14. a history of moderate or severe traumatic brain injury (TBI; loss of consciousness >30 minutes69) 15. left-handedness 16. any contraindications for MRI


NCT ID:

NCT03539432


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Albuquerque, New Mexico 87106
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.